⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001818245

Bhat Laxminarayan

Reports to the SEC for 1 company · CUPERTINO, CA

Transactions

8

Companies

1

Filings

4

CIK

0001818245

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-18	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+109K sh	—	—	109,150
2026-03-18	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+40.9K sh	—	—	40,925
2025-02-13	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+519K sh	—	—	519,000
2025-02-13	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+182K sh	—	—	181,500
2024-09-15	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+158K sh	—	—	158,451
2024-09-15	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+77.8K sh	—	—	77,843
2023-04-25	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+443K sh	—	—	443,000
2023-04-25	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+150K sh	—	—	150,000

Recent filings

4

Accepted (ET)
Mar 204
Bhat Laxminarayan0001437749-26-009258
SEC(opens sec.gov)
Feb 184
Bhat Laxminarayan0001437749-25-004220
SEC(opens sec.gov)
Sep 174
Bhat Laxminarayan0001437749-24-029388
SEC(opens sec.gov)
Apr 274
Bhat Laxminarayan0001437749-23-011381
SEC(opens sec.gov)

Companies

1

REVIVA PHARMACEUTICALS HOLDINGS, INC.Director, President and CEORVPH

Address

C/O REVIVA PHARMACEUTICALS HOLDINGS, INC 10080 N. WOLFE RD., SUITE SW3-200

CUPERTINO, CA, 95014